Valuation: Diaceutics PLC

Market Cap 12Cr 17Cr 14Cr 13Cr 23Cr 1.58TCr 23Cr 157.48Cr 62Cr 792.94Cr 62Cr 61Cr 2.64TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 11Cr 16Cr 13Cr 13Cr 22Cr 1.48TCr 22Cr 147.45Cr 58Cr 742.47Cr 58Cr 57Cr 2.47TCr EV / Sales 2026 *
2.45x
EV / Sales 2027 * 1.95x
Free-Float
71.95%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
3 months+19.76%
6 months+19.76%
Current year+46.28%
Current year 1.67
Extreme 1.67
2.51
1 year 1.67
Extreme 1.67
2.51
3 years 1.67
Extreme 1.67
2.51
5 years 1.05
Extreme 1.05
2.51
10 years 1.05
Extreme 1.05
2.51
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-.--% - - 17Cr
+8.88%+47.73%+305.61%+1,366.10% 6.99TCr
+2.57%+3.25% - - 584.63Cr
-0.57%+5.58% - - 380.76Cr
+1.74%+4.64%+2.59%+39.21% 359.5Cr
+10.00%+12.95%+25.13%+138.85% 337.43Cr
-1.29%+3.22% - - 296.48Cr
+1.61%+2.81%-20.28%-22.23% 140.24Cr
+2.09%-1.06%-41.70%+46.16% 139.77Cr
Average +2.51%+9.64%+54.27%+313.62% 1.15TCr
Weighted average by Cap. +7.30%+37.53%+268.23%+1,206.67%

Financials

2026 *2027 *
Net sales 4.67Cr 6.33Cr 5.47Cr 5.14Cr 8.78Cr 605.24Cr 8.93Cr 60Cr 24Cr 303.08Cr 24Cr 23Cr 1.01TCr 5.63Cr 7.63Cr 6.59Cr 6.2Cr 11Cr 729.91Cr 11Cr 73Cr 28Cr 365.52Cr 29Cr 28Cr 1.21TCr
Net income -11L -14.9L -12.87L -12.1L -20.68L -14Cr -21.02L -1.42Cr -55.41L -7.14Cr -55.95L -54.74L -24Cr 15L 20.32L 17.55L 16.49L 28.2L 19Cr 28.67L 1.93Cr 75.56L 9.73Cr 76.3L 74.64L 32Cr
Net Debt -77.8L -1.05Cr -91.04L -85.55L -1.46Cr -100.79Cr -1.49Cr -10Cr -3.92Cr -50Cr -3.96Cr -3.87Cr -167.73Cr -1.21Cr -1.64Cr -1.42Cr -1.33Cr -2.27Cr -156.71Cr -2.31Cr -16Cr -6.09Cr -78Cr -6.15Cr -6.02Cr -260.78Cr
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.440GBP
Average target price
2.130GBP
Spread / Average Target
+47.92%

Quarterly revenue - Rate of surprise